Amarin Corp Plcuk (AMRN) Change in Acquisitions & Divestments (2020 - 2026)

Amarin Corp Plcuk (AMRN) reported Change in Acquisitions & Divestments of $42.5 million for Q1 2026, down 22.73% year-over-year from $55.0 million in Q1 2025, and down 9.58% quarter-over-quarter from $47.0 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $42.5 million in Q1 2026.

  • Change in Acquisitions & Divestments for Q1 2026 came in at $42.5 million, down 22.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $196.8 million (down 12.84% YoY), and the FY2025 annual result was $209.3 million, down 10.09% from the prior year.
  • Change in Acquisitions & Divestments retreated to $42.5 million in Q1 2026 per AMRN's latest filing, from $47.0 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $113.2 million in Q1 2022 and troughed at $16.9 million in Q4 2022.
  • A 5-year average of $54.8 million and a median of $54.2 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
  • The sharpest annual moves came in 2022 and 2024: Change in Acquisitions & Divestments slumped 79.42% in 2022, then soared 88.38% in 2024.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $16.9 million in 2022, then soared by 72.19% to $29.1 million in 2023, then jumped by 61.45% to $47.0 million in 2024, then gained by 0.0% to $47.0 million in 2025, then slipped by 9.58% to $42.5 million in 2026.
  • Business Quant data shows AMRN's Change in Acquisitions & Divestments at $42.5 million in Q1 2026, $47.0 million in Q4 2025, and $57.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 42.50 Mn
Mar 31, 2026 42.50 Mn
Dec 31, 2025 47.00 Mn
Dec 31, 2025 47.00 Mn
Sep 30, 2025 57.00 Mn
Sep 30, 2025 57.00 Mn
Jun 30, 2025 50.30 Mn
Jun 30, 2025 50.30 Mn
Mar 31, 2025 55.00 Mn
Mar 31, 2025 55.00 Mn
Dec 31, 2024 47.00 Mn
Dec 31, 2024 47.00 Mn
Sep 30, 2024 52.80 Mn
Sep 30, 2024 52.80 Mn
Jun 30, 2024 71.00 Mn
Jun 30, 2024 71.00 Mn
Mar 31, 2024 62.00 Mn
Mar 31, 2024 62.00 Mn
Dec 31, 2023 29.11 Mn
Dec 31, 2023 29.11 Mn